EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 50 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $361,000 | -1.6% | 31,500 | 0.0% | 0.14% | -19.0% |
| Q4 2016 | $367,000 | -13.0% | 31,500 | 0.0% | 0.18% | +20.9% |
| Q3 2016 | $422,000 | -74.9% | 31,500 | -62.8% | 0.15% | -94.4% |
| Q2 2016 | $1,678,000 | +18.2% | 84,680 | 0.0% | 2.64% | +1.9% |
| Q1 2016 | $1,420,000 | – | 84,680 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
| P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
| Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
| 683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
| KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
| Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
| TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
| Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
| CAXTON CORP | 94,083 | $833,000 | 0.54% |